Cargando…

Development and validation of a prognostic nomogram for IgA nephropathy

IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian, Duan, Shuwei, Chen, Pu, Cai, Guangyan, Wang, Yong, Tang, Li, Liu, Shuwen, Zhou, Jianhui, Wu, Di, Shen, Wanjun, Chen, Xiangmei, Wu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706880/
https://www.ncbi.nlm.nih.gov/pubmed/29212234
http://dx.doi.org/10.18632/oncotarget.21721
_version_ 1783282306713124864
author Liu, Jian
Duan, Shuwei
Chen, Pu
Cai, Guangyan
Wang, Yong
Tang, Li
Liu, Shuwen
Zhou, Jianhui
Wu, Di
Shen, Wanjun
Chen, Xiangmei
Wu, Jie
author_facet Liu, Jian
Duan, Shuwei
Chen, Pu
Cai, Guangyan
Wang, Yong
Tang, Li
Liu, Shuwen
Zhou, Jianhui
Wu, Di
Shen, Wanjun
Chen, Xiangmei
Wu, Jie
author_sort Liu, Jian
collection PubMed
description IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicting the IgAN prognosis. 349 patients with IgAN at The Chinese People’s Liberation Army General Hospital were retrospectively analyzed from data between 2000 and 2006. A nomogram was developed using COX regression coefficients to predict decline of estimate Glomerular filtration rate (eGFR) ≥ 50% and end-stage renal disease (ESRD). The discriminative ability and predictive accuracy of the nomogram was determined via concordance index (C-index) and calibration curve. The results were verified in an independent validation cohort. In the derivation cohort, the nomogram was developed using mesangial hypercellularity, tubular atrophy/interstitial fibrosis, average proteinuria (A-P), and average mean arterial pressure (A-MAP) during hospitalization. The C-index of the nomogram was 0.88 (95% CI, 0.80 to 0.96). The calibration curve showed good agreement between prediction and actual observation. Furthermore, the nomogram demonstrated good discrimination (C-index = 0.87, 95% CI 0.78 to 0.95) and calibration in the validation cohort. The nomogram could predict the prognosis of IgAN effectively and intuitively.
format Online
Article
Text
id pubmed-5706880
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57068802017-12-05 Development and validation of a prognostic nomogram for IgA nephropathy Liu, Jian Duan, Shuwei Chen, Pu Cai, Guangyan Wang, Yong Tang, Li Liu, Shuwen Zhou, Jianhui Wu, Di Shen, Wanjun Chen, Xiangmei Wu, Jie Oncotarget Research Paper IgA nephropathy (IgAN) shows strong heterogeneity between individuals. IgAN prognosis is associated with pathological lesions and clinical indicators. However, simple tools for evaluating the clinical prognosis remain inadequate. Our objective was to develop an intuitive estimation tool for predicting the IgAN prognosis. 349 patients with IgAN at The Chinese People’s Liberation Army General Hospital were retrospectively analyzed from data between 2000 and 2006. A nomogram was developed using COX regression coefficients to predict decline of estimate Glomerular filtration rate (eGFR) ≥ 50% and end-stage renal disease (ESRD). The discriminative ability and predictive accuracy of the nomogram was determined via concordance index (C-index) and calibration curve. The results were verified in an independent validation cohort. In the derivation cohort, the nomogram was developed using mesangial hypercellularity, tubular atrophy/interstitial fibrosis, average proteinuria (A-P), and average mean arterial pressure (A-MAP) during hospitalization. The C-index of the nomogram was 0.88 (95% CI, 0.80 to 0.96). The calibration curve showed good agreement between prediction and actual observation. Furthermore, the nomogram demonstrated good discrimination (C-index = 0.87, 95% CI 0.78 to 0.95) and calibration in the validation cohort. The nomogram could predict the prognosis of IgAN effectively and intuitively. Impact Journals LLC 2017-10-10 /pmc/articles/PMC5706880/ /pubmed/29212234 http://dx.doi.org/10.18632/oncotarget.21721 Text en Copyright: © 2017 Liu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Liu, Jian
Duan, Shuwei
Chen, Pu
Cai, Guangyan
Wang, Yong
Tang, Li
Liu, Shuwen
Zhou, Jianhui
Wu, Di
Shen, Wanjun
Chen, Xiangmei
Wu, Jie
Development and validation of a prognostic nomogram for IgA nephropathy
title Development and validation of a prognostic nomogram for IgA nephropathy
title_full Development and validation of a prognostic nomogram for IgA nephropathy
title_fullStr Development and validation of a prognostic nomogram for IgA nephropathy
title_full_unstemmed Development and validation of a prognostic nomogram for IgA nephropathy
title_short Development and validation of a prognostic nomogram for IgA nephropathy
title_sort development and validation of a prognostic nomogram for iga nephropathy
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706880/
https://www.ncbi.nlm.nih.gov/pubmed/29212234
http://dx.doi.org/10.18632/oncotarget.21721
work_keys_str_mv AT liujian developmentandvalidationofaprognosticnomogramforiganephropathy
AT duanshuwei developmentandvalidationofaprognosticnomogramforiganephropathy
AT chenpu developmentandvalidationofaprognosticnomogramforiganephropathy
AT caiguangyan developmentandvalidationofaprognosticnomogramforiganephropathy
AT wangyong developmentandvalidationofaprognosticnomogramforiganephropathy
AT tangli developmentandvalidationofaprognosticnomogramforiganephropathy
AT liushuwen developmentandvalidationofaprognosticnomogramforiganephropathy
AT zhoujianhui developmentandvalidationofaprognosticnomogramforiganephropathy
AT wudi developmentandvalidationofaprognosticnomogramforiganephropathy
AT shenwanjun developmentandvalidationofaprognosticnomogramforiganephropathy
AT chenxiangmei developmentandvalidationofaprognosticnomogramforiganephropathy
AT wujie developmentandvalidationofaprognosticnomogramforiganephropathy